Erythropoietin in the critically ill - is it more than just blood?

被引：4
作者：
Corwin, HL [1 ]
机构：
[1] Dartmouth Coll Sch Med, Lebanon, NH USA
[2] Dartmouth Hitchcock Med Ctr, Intens Care Unit, Lebanon, NH 03766 USA
来源：
CRITICAL CARE | 2004年 / 8卷 / 05期
关键词：
apoptosis; erythropoietin; sepsis;
D O I：
10.1186/cc2949
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the critically ill.
引用
收藏
页码：325 / 326
页数：2
相关论文
共 12 条
  • [1] Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury
    Brines, ML
    Ghezzi, P
    Keenan, S
    Agnello, D
    de Lanerolle, NC
    Cerami, C
    Itri, LM
    Cerami, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) : 10526 - 10531
  • [2] The immunopathogenesis of sepsis
    Cohen, J
    [J]. NATURE, 2002, 420 (6917) : 885 - 891
  • [3] Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?
    Coleman, T
    Brines, M
    [J]. CRITICAL CARE, 2004, 8 (05): : 337 - 341
  • [4] Efficacy of recombinant human erythropoietin in critically ill patients - A randomized controlled trial
    Corwin, HL
    Gettinger, A
    Pearl, RG
    Fink, MP
    Levy, MM
    Shapiro, MJ
    Corwin, MJ
    Colton, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (22): : 2827 - 2835
  • [5] Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
    Corwin, HL
    Gettinger, A
    Rodriguez, RM
    Pearl, RG
    Gubler, KD
    Enny, G
    Colton, T
    Corwin, MJ
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (11) : 2346 - 2350
  • [6] Erythropoietin therapy for acute stroke is both safe and beneficial
    Ehrenreich, H
    Hasselblatt, M
    Dembowski, C
    Cepek, L
    Lewczuk, P
    Stiefel, M
    Rustenbeck, HH
    Breiter, N
    Jacob, S
    Knerlich, F
    Bohn, M
    Poser, W
    Rüther, E
    Kochen, M
    Gefeller, O
    Gleiter, C
    Wessel, TC
    De Ryck, M
    Itri, L
    Prange, H
    Cerami, A
    Brines, M
    Sirén, AL
    [J]. MOLECULAR MEDICINE, 2002, 8 (08) : 495 - 505
  • [7] Erbayraktar Serhat, 2003, Curr Hematol Rep, V2, P465
  • [8] Epoetin alfa - Clinical evolution of a pleiotropic cytokine
    Henry, DH
    Bowers, P
    Romano, MT
    Provenzano, R
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (03) : 262 - 276
  • [9] Medical progress: The pathophysiology and treatment of sepsis.
    Hotchkiss, RS
    Karl, IE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02) : 138 - 150
  • [10] Liu XZ, 1997, J NEUROSCI, V17, P5395
12